维普中文期刊产品整合服务
814篇 您的检索式:作者名="Koenig W"
    题名 作者 年代 出处 被引量
1酒精摄入、心脏生物标志物和心房颤动风险与不良结局显示文摘酒精摄入和新发心房颤动相关性证据不一,尤其是在低剂量下。该研究评估欧洲队列在整个饮酒范围内酒精摄入、生物标志物和新发心房颤动的关系。方法和结果:在一个以社区为基础的汇集队列中,研究者随访107845人,以评估酒精摄入(酒精种类和饮酒方式)与新发心房颤动的关系。研究者收集经典心血管病危险因素和新发心力衰竭的信息,并检测生物标记物氨基末端脑钠肽前体和高敏肌钙蛋白I。陈嘉睿(译) 练桂丽((审校) Csengeri D Sprünker NA Di Castelnuovo A Niiranen T Vishram-Nielsen JK Costanzo S S derberg S Jensen SM Vartiainen E Donati MB Magnussen C Camen S Gianfagna F L chen ML Kee F Kontto J Mathiesen EB Koenig W Stefan B de Gaetano G J rgensen T Kuulasmaa K Zeller T Salomaa V Iacoviello L Schnabel RB 2021中华高血压杂志2021,29,2:9
2Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis显示文摘BACKGROUND Non-alcoholic steatohepatitis(NASH) has become one of the leading causes of liver disease in the western world. In obese patients weight reduction is recommended. Up to now there are no specific guidelines for weight loss in order to reduce hepatic fat content.AIM To investigate the effects of a 24-wk guided lifestyle intervention program compared to a meal replacement regimen based on soy protein.METHODS Twenty-six subjects with NASH participated in a randomized single-center study. They were randomly assigned to either meal replacement group(MR-G)with soy-yogurt-honey preparation or to guided lifestyle change group(LC-G)with endurance activity and nutrition counselling. Serum alanine transaminase(ALT), aspartate transaminase(AST), lipid parameters, and adipokines were measured. Liver fat content and lipid composition were determined by magnetic resonance imaging and magnetic resonance spectroscopy. Body fat mass and lean body mass were assessed using Bod Pod? device. Pre-and post-intervention monitoring of parameters was performed. Statistical analyses were conducted with SPSS software, results were expressed as median(interquartile range).RESULTS Twenty-two subjects(MR-G, n = 11 and LC-G, n = 11) completed the study(9 women, 13 men; age 52.1(15.0) years, body mass index(BMI) 32.3(3.3) kg/m^2).In both groups a significant weight loss was achieved(MR-G:-6.4(3.6) kg, P <0.01; LC-G:-9.1(10.4) kg, P < 0.01). BMI dropped in both groups(MR-G:-2.3(1.5)kg/m^2, P = 0.003; LC-G:-3.0(3.4) kg/m^2, P = 0.006). Internal fat and hepatic lipid content were markedly reduced in both groups in comparable amount. There was a strong correlation between reduction in liver fat and decrease in ALT.Likewise, both groups showed an improvement in glycemic control and lipid profile. Changes in adipokines, particularly in adiponectin and leptin were closely related to intrahepatic lipid changes.CONCLUSION Comprehensive lifestyle intervention and meal replacement regimen have comparable effects on body and liver fat, as well as decrease in markers of hepatic inflammation among NASH patients.Peter Deibert Adhara Lazaro Denise Schaffner Aloys Berg Daniel Koenig Wolfgang Kreisel Manfred W Baumstark Daniel Steinmann Martin Buechert Thomas Lange 2019World Journal of Gastroenterology2019,25,9:3
3Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4) 显示文摘HERDER C KOLB H KOENIG W 2006Diabetes Care2006,29,2:1
4Epidemiology of chronic kidney disease: results from a population of older adults in Germany 显示文摘Zhang QL Koenig W Raum E 2009Prey Med2009,48,2:1
5Quality definitions and assessment in drilling of fiher reinforced thermoses显示文摘W Koenig P Grab 1989Ann CIRP1989,38,1:1
6Lipoprotein-associated phespholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population : results from the 14-year follow-up of a large cohort from southern Germany显示文摘Koenig W Khuseyinova N Lowel H 2004Circulation2004,110,:1
7Comparison of N - terminal pro- B - natriuretic peptide, C - reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease 显示文摘Rothenbacher D Koenig W Brenner H 2006Arch Intern Med2006,166,22:1
8Cystatin C and cardiovascular risk 显示文摘Taglieri N Koenig W Kaski JC 2009ClinChem2009,55,11:1
9Die Bedeutung der Regenwasserbewirtschaftung显示文摘Klaus W Koenig 2003Umweltpraxis2003,,1:1
10Cystain C and cardiovascular risk 显示文摘Taglier N Koenig W Kaski JC 2010Ann Biol Clin(Pails)2010,68,5:1
11Plasma fibrin D - dimer levels and risk of stable coronary artery disease results of a large case - control study 显示文摘Koenig W Rotbenbacher D Hoffmeister A 2001Arterioscl Thromb Vascul Biolo2001,21,10:1
12Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events:more than simply a marker of glomerular filtration rate显示文摘Koenig W Twardella D Brenner H 2005Clin Chem2005,51,2:1
13The Release of Alginate Lyase from Growing Pseudomonas syringae pathovar phaseolicola显示文摘OTT C M DAY D F KOENIG D W 2001Current Microbiology2001,42,2:1
14C- reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992显示文摘Koenig W Sund M Froblich M 1999Circulation1999,99,2:1
15Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C reactive protein in apparently healthy middleaged men from the general population:results from the 14-year follow up of a large cohort from southern Germany显示文摘Koenig W Khuseyinova N Lowel H 2004Circulation2004,110,:1
16C-reactive protein modulates risk prediction based on the Framingham score:implications for future risk assessment:resuits from a large cohort study in southern Germany 显示文摘Koenig W Lowel H Baumert J 2004Circulation2004,109,:1
17Association of systemic coneent rations of macrophage migration inhibitory factor with impaired glucose tole-rance and type 2 diabetes:results from the Cooperative Health Research in the Region of Angsburg,Survey 4 (KORA S4)显示文摘Herder C Kolb H Koenig W 2006Diabetes Care2006,29,2:1
18Serum amyloid P component and cardiovascular disease:is there a sensible link 显示文摘Koenig W 0,,04:1
19High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy显示文摘Koenig W 2013Int J Cardiol2013,68,:1
20Utility of inflammatory markers in the management of coronary artery disease 显示文摘Rosenson RS Koenig W 2003Am J Cardiol2003,92,1:1
返回顶部 每页显示:
共41页 首页 上一页 第1页 下一页 末页 /41 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费